- Arcelik reported a net loss of 2.34 billion liras for the second quarter of 2025.
- This net loss compares to a net profit of 20.3 billion liras in the same quarter the previous year.
- The estimated net loss for the quarter was 1.36 billion liras, which Arcelik exceeded.
- Sales for the quarter reached 121.36 billion liras, marking a 12% decline year-over-year.
- The sales figure was slightly below the anticipated estimate of 122.2 billion liras.
- In terms of stock recommendations, Arcelik has 11 “buy” ratings, 9 “hold” ratings, and 0 “sell” ratings.
A look at Arcelik AS Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 1 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using the Smartkarma Smart Scores system have evaluated the long-term outlook for Arcelik AS, a company that specializes in manufacturing and selling various home appliances and consumer electronics products. The scores for Arcelik AS indicate a strong value proposition with a score of 4, highlighting the company’s solid financial standing and attractive valuation. However, the company’s dividend score is comparatively low at 1, suggesting a lower dividend payout.
Arcelik AS also received a score of 3 for growth, indicating moderate prospects for future expansion and development. In terms of resilience and momentum, the company scored 2 in each category, signifying a moderate level of stability and market momentum. Overall, while Arcelik AS demonstrates good value and growth potential, investors may consider the lower dividend score and moderate resilience and momentum factors in their long-term investment decisions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
